Metformin therapy and circulating NT-proBNP levels: the CAMERA trial

Metformin therapy and circulating NT-proBNP levels: the CAMERA trial

書誌詳細
主要な著者:	Preiss, D, Welsh, P, Sattar, N
フォーマット:	Journal article
出版事項:	American Diabetes Association 2016

類似資料

The integration of BNP and NT-proBNP into clinical medicine
著者:: Swiss Medical Weekly
出版事項: (2007-01-01)

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
著者:: Benedikt Seither, 等
出版事項: (2024-11-01)

In-hospital mortality is associated with high NT-proBNP level.
著者:: Malik Benmachiche, 等
出版事項: (2018-01-01)

Sendaway capillary NT-proBNP in pulmonary hypertension
著者:: Eleanor Morris, 等
出版事項: (2024-07-01)

The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
著者:: Angeliki Mouzarou, 等
出版事項: (2025-01-01)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
著者:: A Palazzuoli, 等
出版事項: (2010-05-01)

Highly sensitive detection of NT-proBNP by molecular motor
著者:: Jie Zhang, 等
出版事項: (2017-03-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
著者:: Aidonis Rammos, 等
出版事項: (2023-08-01)

Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy
著者:: Maya Risteska, 等
出版事項: (2022-10-01)

NT-proBNP and prognostics variables in acute myocardial infarction
著者:: Jorge Vendrell Cabrera, 等
出版事項: (2012-01-01)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
著者:: Yuancheng Zhao, 等
出版事項: (2023-12-01)

Association between NT-proBNP Level and the Severity of COVID-19 Pneumonia
著者:: Lan Wang, 等
出版事項: (2021-01-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
著者:: H.M. Kim, 等
出版事項: (2020-08-01)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
著者:: Robert A. Lewis, 等
出版事項: (2020-05-01)

SST2 and NT-proBNP biomarkers in prediction of COVID-19
著者:: O.O. Samchuk, 等
出版事項: (2023-06-01)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
著者:: Reinhard Henrik, 等
出版事項: (2011-08-01)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
著者:: Gina Sado, 等
出版事項: (2024-12-01)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
著者:: Huiqi Jiang, 等
出版事項: (2019-05-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
著者:: Yu. V. Dubolazova, 等
出版事項: (2017-02-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
著者:: Chin-Shern Lau, 等
出版事項: (2022-05-01)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
著者:: Maria António, 等
出版事項: (2023-07-01)

Using NT-proBNP as a criterion for heart failure hospitalization
著者:: Babak Tamizifar, 等
出版事項: (2012-01-01)

NT-proBNP na estratificação de risco no tromboembolismo pulmonar
著者:: Hélder Dores, 等
出版事項: (2011-12-01)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
著者:: Lucian MURESAN, 等
出版事項: (2017-06-01)

NT-proBNP in Myocarditis after a Scorpion Sting Envenomation
著者:: Suresh V Sagarad, 等
出版事項: (2013-01-01)

NT-proBNP and Echocardiographic Parameters in Patients with Acute Heart Failure
著者:: Radek Pudil, 等
出版事項: (2007-01-01)

The effect of metformin treatment on the level of GLP-1, NT-proBNP and endothelin-1 in patients with type 2 diabetes mellitus
著者:: L.K. Sokolova, 等
出版事項: (2020-11-01)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
著者:: Hussein Alawieh, 等
出版事項: (2019-11-01)

The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV
著者:: Mads-Holger Bang Jacobsen, 等
出版事項: (2023-01-01)

Pretransplant NT‐proBNP levels are associated with mortality among lung transplant recipients
著者:: Shimon Izhakian, 等
出版事項: (2024-07-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
著者:: V. I. Podzolkov, 等
出版事項: (2023-01-01)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
著者:: Bader Alsuwailem, 等
出版事項: (2021-01-01)

A Point-of-Care Measurement of NT-proBNP for Heart Failure Patients
著者:: Cesar Navarro, 等
出版事項: (2020-01-01)

Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure
著者:: Kanako Teramoto, 等
出版事項: (2024-05-01)

NT-proBNP, Cardiometabolic Risk Factors, and Nutritional Status in Hemodialysis Patients
著者:: Jacques Ducros, 等
出版事項: (2017-01-01)

Prognostic value of NT-proBNP in the new era of heart failure treatment.
著者:: Dat Vu Nguyen, 等
出版事項: (2024-01-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
著者:: I. A. Kozlov, 等
出版事項: (2023-02-01)

Analytical and clinical performance evaluation of a new NT-proBNP assay
著者:: Pingfeng Feng, 等
出版事項: (2024-07-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
著者:: Irina Cuciureanu, 等
出版事項: (2021-03-01)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
著者:: Paweł Komarnicki, 等
出版事項: (2023-09-01)